Key Health Benefits Supports healthy weight management and body composition Promotes satiety and helps manage food cravings Supports healthy blood sugar, insulin utilization, and metabolic function Helps maintain lean muscle mass and abdominal trimness Supports cholesterol maintenance and cardiometabolic health Strengthens gut barrier function and digestive comfort Conditions Supported Weight management and metabolic imbalance Insulin resistance and blood sugar dysregulation Increased appetite, cravings, or overeating patterns Gut dysbiosis and digestive discomfort Inflammatory stress within the intestinal tract Cardiometabolic risk factors associated with poor gut health Why Choose EVEXIAS Health Solutions Nutraceuticals
hCG can also be used to help restore spermatogenesis in men hypogonadal hypogonadism or steroid-induced impairment of spermatogenesis
Anyone promising you faster is either lucky or lying." Dr
CagriSema is two drugs in one syringe
FOXO4-DRI Key Research Facts Full name: FOXO4 D-Retro-Inverso peptide (FOXO4-DRI) Classification: Cell-penetrating senolytic peptide FOXO4/p53 protein-protein interaction inhibitor Design: D-retro-inverso isoform of FOXO4s p53-binding domain reversed sequence with all D-amino acids Binding target: p53 transactivation domain 2 (TAD2) displaces FOXO4 from the FOXO4-p53 complex Mechanism: FOXO4-DRI binds p53 TAD2 p53 nuclear exclusion p53 mitochondrial translocation BAX activation caspase-3 cleavage senescent cell-selective apoptosis Selectivity basis: FOXO4 is upregulated in senescent cells but expressed at low levels in most non-senescent adult cells selectivity is mechanistically conferred D-amino acid advantage: Proteolytic stability resistant to intracellular peptidases that would rapidly degrade equivalent L-amino acid sequences Structural characterisation: NMR structural models of FOXO4-DRI/p53TAD2 complex resolved (Nature Communications, 2025) confirms disordered-to-ordered transition upon binding Research cell types studied: IMR90 fibroblasts, TM3 Leydig cells, endothelial cells, chondrocytes, keloid fibroblasts, HCT116 cancer cells In vitro working concentration: 25 M used in multiple published studies for senescent cell apoptosis induction What Does FOXO4-DRI Do in Research
